Genetically predicted HLA-DR+ natural killer cells as potential mediators in the lipid-coronary artery disease/

Dingding Qian1, Haoyue Zhang2, Rong Liu2

  • 1Department of Cardiology, Lihuili Hospital Affiliated to Ningbo University, Ningbo University, Ningbo, Zhejiang, China.

Frontiers in Immunology
|September 13, 2024
PubMed

Insights

This study reveals genetic links between lipid levels and coronary artery disease (CAD) risk, identifying specific lipids and natural killer cells as potential therapeutic targets for CAD.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiovascular Disease Research
  • Immunology

Background:

  • Coronary artery disease (CAD) presents a major global health challenge.
  • Understanding the genetic basis of CAD is crucial for developing novel therapeutic strategies.
  • This research investigates the genetic connections between lipid profiles, immune cell phenotypes, and CAD risk.

Purpose of the Study:

  • To explore the genetic associations between lipid profiles and CAD risk using Mendelian randomization (MR).
  • To identify specific lipid and immune cell phenotypes contributing to CAD pathogenesis.
  • To examine immune cell phenotypes as potential mediators in the lipid-CAD causal pathway.

Main Methods:

  • Utilized large-scale genome-wide association study (GWAS) data.
  • Analyzed 179 lipid and 731 immune cell phenotypes for genetic links to CAD and coronary artery calcification (CAC).
  • Employed Mendelian randomization (MR) to assess causal relationships and mediation effects.

Main Results:

  • Identified 36 lipids with a genetic causal relationship to CAD; 29 were risk factors, 7 were protective.
  • Found 18 shared lipids, including triacylglycerols and diacylglycerols, as risk factors for both CAD and CAC.
  • Discovered HLA DR+ natural killer cells as potential mediators in the causal pathway between certain lipids and CAD.

Conclusions:

  • The study offers preliminary insights into the genetic interplay between lipid metabolism, immune cell function, and CAD susceptibility.
  • Highlights natural killer cells as potential mediators in the lipid-CAD/CAC pathway, suggesting novel therapeutic targets.
  • Further research is needed to validate these findings and their clinical implications.
Abstract